Beware of breast implant users in the risk of cancer
The US Food and Drug Administration (FDA) has warned about the risk of squamous cell carcinoma and lymphoma cancer Lymph nodes in breast cancer patients.
This warning is based on the number of case reports related to breast implants that the FDA has received.
Squamous cell carcinoma is a type of skin cancer that forms in the scar around the breast implant site. Also, breast implants are associated with the appearance of lymphomas or blood cancers that develop in the lymphatic system.
Citing CNN, the FDA reported that although the incidence of breast cancer and lymphomas associated with breast implants may be rare, people who have breast cancer or who are considering and getting breast cancer they should be aware of the risks.
As of September 1, 2022, the FDA has received 10 reports of squamous cell carcinoma and 12 reports of various lymphomas associated with the implant.
The FDA says that people who have had breast implants should know what signs to look out for regarding the risk of breast cancer. Some of the symptoms to look out for include swelling, pain, inflammation and changes in the skin.
The FDA also confirmed that it will continue to review sources reporting on squamous cell carcinoma and will consider the incidence of cancer in the capsule around the tumor. milk.
However, the incidence and causes of cancer are still uncertain.
The Relationship of Breast Implants to Systemic Diseases
Breast involvement has been reported since the 1960s in association with systemic diseases such as immunodeficiency.
In 2011, the FDA first identified a link between breast cancer and the development of a rare cancer called anaplastic large cell lymphoma. Meanwhile, in 2019, the pharmaceutical company Allergen was asked to withdraw Biocell breast implant products worldwide because it was linked to a rare cancer.
Last year, the FDA made several changes to breast implant regulations, including a new label with a warning box and a patient checklist telling people that the implant is not a life-saving medical device.
The FDA has decided to limit the sale of breast milk products to health care providers who provide patients with an accurate list of ingredients that explain the risks.
The FDA said in a statement that, although most do not have serious problems, 20 percent of women who use the device have problems and have it removed after 8 to 10 years.
The bigger the breast implant, the more health risks it poses, and these risks may require more surgery.